Texas Capital Bank Wealth Management Services Inc bought a new position in Danaher Corporation (NYSE:DHR – Free Report) during the 2nd quarter, Holdings Channel reports. The fund bought 41,817 shares of the conglomerate’s stock, valued at approximately $7,965,000.
A number of other hedge funds also recently made changes to their positions in DHR. Main Street Group LTD purchased a new position in Danaher during the 1st quarter valued at approximately $25,000. N.E.W. Advisory Services LLC bought a new stake in Danaher in the 2nd quarter worth approximately $25,000. JPL Wealth Management LLC purchased a new stake in shares of Danaher during the 3rd quarter worth approximately $25,000. Elevated Capital Advisors LLC purchased a new stake in shares of Danaher during the 4th quarter worth approximately $26,000. Finally, WFA of San Diego LLC bought a new position in shares of Danaher during the 2nd quarter valued at approximately $26,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.
Danaher Price Performance
DHR stock opened at $199.62 on Wednesday. The stock has a market cap of $140.33 billion, a PE ratio of 35.46, a P/E/G ratio of 2.52 and a beta of 0.78. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a 50-day moving average price of $193.74 and a 200 day moving average price of $192.50. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on the stock. Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. Morgan Stanley lowered their price objective on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Stifel Nicolaus dropped their price objective on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. HSBC reduced their target price on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Finally, Citigroup began coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $228.91.
Check Out Our Latest Analysis on DHR
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
- Five stocks we like better than Danaher
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
